AUS
NZ
UK
CA
USA
IND
_06_19_2026_12_34_15_139937.jpg)
The CSL Limited (ASX:CSL) share price, reflecting the challenges in recent months, closed at $258.21, experiencing a 0.9% decline for the day. This ASX healthcare stock encountered a new 52-week low of $228.65 in late October. However, the past few weeks have witnessed a rebound, with CSL demonstrating a noteworthy 11.95% gain since October 30 and an almost 13% recovery since reaching the recent low..
However, the question on many investors' minds is whether ASX CSL can reclaim its historic highs and reach $300 by Christmas. The company's all-time highs in early 2020 surpassed $340 a share, making the current landscape seem distant from those peaks.
To assess the likelihood of CSL hitting $300 a share by Christmas, a speculative analysis is conducted. Given the absence of significant announcements or events scheduled by CSL before the year-end, such as earnings reports or quarterly updates, the potential for a substantial price movement in the next ~35 days is limited.
While buy ratings from ASX brokers could influence the CSL share price, recent bullish views from brokers, including UBS with a 12-month share price target of $340, make the path to $300 before Christmas appear improbable.
While nothing in the market is certain, and unexpected events can occur, the analysis suggests that CSL reaching $300 a share by Christmas is unlikely based on the current information available. Investors are reminded of the inherent uncertainties in predicting short-term movements in the stock market.
